MTOR and neoplasm: The combination of the GLI1/2 inhibitor GANT61 and the PI3K/mTOR inhibitor PI103 synergistically induces apoptosis in RMS cell lines and primary cells (CI < 0.2) and suppresses clonogenicity, three-dimensional growth, and in vivo tumor progression.